Eunomia perspective · 2025-10-24 · Compliance Programmes, Audits & Training, HCP Engagement & Transparency Reporting
Staying Ahead of the Curve: Audit-Readiness Best Practices Across European Life Sciences Markets
Published by Eunomia Pharma Services · Updated
How can European life sciences companies stay audit-ready?
By treating audit readiness as a continuous discipline rather than an annual checkpoint. The article sets out four practices: harmonise SOPs and policies across markets, adopt real-time monitoring of payments and engagements, apply a consistent FMV framework, and train and empower teams.
Four practices
- Standardise policies and SOPs across markets, documenting local variations.
- Monitor payments, sponsorships and engagements as they happen.
- Apply one documented FMV framework everywhere.
- Give teams role-based training and a safe route to raise concerns.
The practical steps above are Eunomia’s operational guidance. See the source notes below for the scope of the external references.
Building a culture of audit readiness
Sources and scope
- SFO: Evaluating a corporate compliance programme
How the UK Serious Fraud Office assesses whether a compliance programme works in practice.
- EFPIA: The EFPIA Code of Practice
The European industry code for promotion and for interactions with HCPs, HCOs and patient organisations, implemented through national codes.
External sources accessed 30 September 2026. Check the applicable country rules and current source text for a specific engagement.
